Literature DB >> 12732107

[The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease].

J P Gisbert1, F Gomollón, J Maté, J M Pajares.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12732107     DOI： 10.1016/s0210-5705(03)70365-3

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN： 0210-5705            Impact factor:   2.102


× No keyword cloud information.
  4 in total

1.  Prevalence of macrocreatinkinase type 1 in patients with inflammatory bowel disease.

Authors:  J L Perez-Calle; I Marin-Jimenez; P Lopez-Serrano; J P Gisbert; A S Pena; C Fernandez-Rodriguez
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

2.  Soluble ST2: a new and promising activity marker in ulcerative colitis.

Authors:  David Díaz-Jiménez; Lucía E Núñez; Caroll J Beltrán; Enzo Candia; Cristóbal Suazo; Manuel Alvarez-Lobos; María-Julieta González; Marcela A Hermoso; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

3.  Diagnostic value of fecal B cell activating factor in patients with abdominal discomfort.

Authors:  C Xie; R Quan; L Wang; C Chen; W Yan; Y Fu
Journal:  Clin Exp Immunol       Date:  2019-08-05       Impact factor: 4.330

Review 4.  Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.

Authors:  Laila Aldars-García; María Chaparro; Javier P Gisbert
Journal:  Microorganisms       Date:  2021-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.